483 related articles for article (PubMed ID: 19103857)
21. Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates.
Al Hosani H; Salah M; Osman HM; Farag HM; Anvery SM
East Mediterr Health J; 2005 May; 11(3):300-7. PubMed ID: 16602448
[TBL] [Abstract][Full Text] [Related]
22. [Sickle cell disease neonatal screening. First evaluation].
Mbodj M; Ndoye O; Diarra M; Mbaye BN; Sow Toure H; Diouf L; Gassama Seck S; Dhondt JL; Farriaux JP
Dakar Med; 2003; 48(3):202-5. PubMed ID: 15776632
[TBL] [Abstract][Full Text] [Related]
23. [Neonatal screening for sickle cell disease in the Consorci Sanitari de Mataro. Rationale and first results].
Cabot Dalmau A; Casado Toda M; Barberán Pérez J; Roqueta Sureda M; Martorell Aymerich Q; Bosch Llobet A; Rovira Fernández JM
An Esp Pediatr; 1998 Aug; 49(2):157-60. PubMed ID: 9773551
[TBL] [Abstract][Full Text] [Related]
24. [Neonatal detection of sickle cell disease].
Bardakdjian-Michau J
J Gynecol Obstet Biol Reprod (Paris); 2003 Feb; 32(1 Suppl):1S61-4. PubMed ID: 12592166
[TBL] [Abstract][Full Text] [Related]
25. Ocular findings in children with homozygous sickle cell disease in the Democratic Republic of Congo.
Kaimbo Wa Kaimbo D; Ngiyulu Makuala R; Dralands L; Missotten L
Bull Soc Belge Ophtalmol; 2000; 275():27-30. PubMed ID: 10853304
[TBL] [Abstract][Full Text] [Related]
26. Starting neonatal screening for haemoglobinopathies in The Netherlands.
Giordano PC
J Clin Pathol; 2009 Jan; 62(1):18-21. PubMed ID: 19103852
[TBL] [Abstract][Full Text] [Related]
27. Challenge of managing sickle cell disease in a pediatric population living in kinshasa, democratic republic of congo: a sickle cell center experience.
Aloni MN; Nkee L
Hemoglobin; 2014; 38(3):196-200. PubMed ID: 24669956
[TBL] [Abstract][Full Text] [Related]
28. [Economic analysis of neonatal screening for drepanocytosis in metropolitan France].
Le Galès C; Galactéros F
Rev Epidemiol Sante Publique; 1994; 42(6):478-92. PubMed ID: 7816961
[TBL] [Abstract][Full Text] [Related]
29. Identifying homozygous sickle cell disease when neonatal screening is not available: a clinic-based observational study.
Hambleton IR; Wierenga KJ
J Med Screen; 2004; 11(4):175-9. PubMed ID: 15563773
[TBL] [Abstract][Full Text] [Related]
30. A prospective newborn screening and treatment program for sickle cell anemia in Luanda, Angola.
McGann PT; Ferris MG; Ramamurthy U; Santos B; de Oliveira V; Bernardino L; Ware RE
Am J Hematol; 2013 Dec; 88(12):984-9. PubMed ID: 24038490
[TBL] [Abstract][Full Text] [Related]
31. The potential of electrospray ionization mass spectrometry for the diagnosis of hemoglobin variants found in newborn screening.
Wild BJ; Green BN; Stephens AD
Blood Cells Mol Dis; 2004; 33(3):308-17. PubMed ID: 15528150
[TBL] [Abstract][Full Text] [Related]
32. Newborn screening for sickle cell disease in a Nigerian hospital.
Odunvbun ME; Okolo AA; Rahimy CM
Public Health; 2008 Oct; 122(10):1111-6. PubMed ID: 18486954
[TBL] [Abstract][Full Text] [Related]
33. Universal newborn screening for haemoglobinopathies in Guadeloupe (French West Indies): a 27-year experience.
Saint-Martin C; Romana M; Bibrac A; Brudey K; Tarer V; Divialle-Doumdo L; Petras M; Keclard-Christophe L; Lamothe S; Broquere C; Etienne-Julan M
J Med Screen; 2013 Dec; 20(4):177-82. PubMed ID: 24144845
[TBL] [Abstract][Full Text] [Related]
34. [Neonatal screening for sickle cell disease at the Nice University Hospital: the last 8 years].
Berthet S; Monpoux F; Soummer AM; Bérard E; Sarles J; Badens C
Arch Pediatr; 2010 Dec; 17(12):1652-6. PubMed ID: 21087846
[TBL] [Abstract][Full Text] [Related]
35. [Acceptability of neonatal screening of the sickle cell disease during the pandemic of COVID-19 in Kisangani, Democratic Republic of the Congo].
Kasai ET; Opara JPAA; Agasa SB; Gulbis B; Uvoya NA; Nguma JDB; Maloba PK; Hubert P; Etienne AM; Djang Eing A RM
Pan Afr Med J; 2020; 37():299. PubMed ID: 33654518
[TBL] [Abstract][Full Text] [Related]
36. An evaluation of the Sebia capillarys Neonat Haemoglobin FAST™ system for routine newborn screening for sickle cell disease.
Murray C; Hall SK; Griffiths P
Int J Lab Hematol; 2011 Oct; 33(5):533-9. PubMed ID: 21535479
[TBL] [Abstract][Full Text] [Related]
37. Newborn screening for sickle cell disease in Kisangani, Democratic Republic of the Congo: an update.
Kasai ET; Gulbis B; Ntukamunda JK; Bours V; Batina Agasa S; Marini Djang'eing'a R; Boemer F; Katenga Bosunga G; Ngbonda Dauly N; Sokoni Vutseme J; Boso Mokili B; Alworong'a Opara JP
Hematology; 2023 Dec; 28(1):2213043. PubMed ID: 37183964
[TBL] [Abstract][Full Text] [Related]
38. The spectrum of haemoglobin variants in two scheduled tribes of Sundargarh district in north-western Orissa, India.
Balgir RS
Ann Hum Biol; 2005; 32(5):560-73. PubMed ID: 16316913
[TBL] [Abstract][Full Text] [Related]
39. Sickle cell disease from Africa to Belgium, from neonatal screening to clinical management.
Lê PQ; Ferster A; Cotton F; Vertongen F; Vermylen C; Vanderfaeillie A; Dedeken L; Heijmans C; Ketelslegers O; Dresse MF; Gulbis B
Med Trop (Mars); 2010 Dec; 70(5-6):467-70. PubMed ID: 21516988
[TBL] [Abstract][Full Text] [Related]
40. Significant prevalence of sickle cell disease in Southwest Germany: results from a birth cohort study indicate the necessity for newborn screening.
Kunz JB; Awad S; Happich M; Muckenthaler L; Lindner M; Gramer G; Okun JG; Hoffmann GF; Bruckner T; Muckenthaler MU; Kulozik AE
Ann Hematol; 2016 Feb; 95(3):397-402. PubMed ID: 26658910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
